Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma
Garcia‐Carbonero, Rocio, Marquez‐Rodas, Ivan, de la Cruz‐Merino, Luis, Martinez‐Trufero, Javier, Cabrera, Miguel Angel, Piulats, Jose Maria, Capdevila, Jaume, Grande, Enrique, Martin‐Algarra, Salvador, Berrocal, Alfonso
Published in The oncologist (Dayton, Ohio) (01.10.2019)
Published in The oncologist (Dayton, Ohio) (01.10.2019)
Get full text
Journal Article
Strategies to design clinical studies to identify predictive biomarkers in cancer research
Luis Perez-Gracia, Jose, Sanmamed, Miguel F, Bosch, Ana, Patiño-Garcia, Ana, Schalper, Kurt A, Segura, Victor, Bellmunt, Joaquim, Tabernero, Josep, Sweeney, Christopher J, Choueiri, Toni K, Martín, Miguel, Pablo Fusco, Juan, Esperanza Rodriguez-Ruiz, Maria, Calvo, Alfonso, Prior, Celia, Paz-Ares, Luis, Pio, Ruben, Gonzalez Billalabeitia, Enrique, Gonzalez Hernandez, Alvaro, Páez, David, María Piulats, Jose, Gurpide, Alfonso, Andueza, Mapi, de Velasco, Guillermo, Pazo, Roberto, Grande, Enrique, Nicolas, Pilar, Abad-Santos, Francisco, Garcia-Donas, Jesus, Castellano, Daniel, Pajares, María J, Suarez, Cristina, Colomer, Ramon, Montuenga, Luis M, Melero, Ignacio
Published in Cancer treatment reviews (01.02.2017)
Published in Cancer treatment reviews (01.02.2017)
Get full text
Journal Article
Ergolide mediates anti-cancer effects on metastatic uveal melanoma cells and modulates their cellular and extracellular vesicle proteomes
Sundaramurthi, Husvinee, Tonelotto, Valentina, Wynne, Kieran, O'Connell, Fiona, O'Reilly, Eve, Costa-Garcia, Marcel, Kovácsházi, Csenger, Kittel, Agnes, Marcone, Simone, Blanco, Alfonso, Pallinger, Eva, Hambalkó, Szabolcs, Piulats Rodriguez, Jose Maria, Ferdinandy, Péter, O'Sullivan, Jacintha, Matallanas, David, Jensen, Lasse D, Giricz, Zoltán, Kennedy, Breandán N
Published in Open research Europe (2023)
Published in Open research Europe (2023)
Get full text
Journal Article
Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells
Etxeberria, Iñaki, Bolaños, Elixabet, Quetglas, Jose I., Gros, Alena, Villanueva, Alberto, Palomero, Jara, Sánchez-Paulete, Alfonso R., Piulats, Jose María, Matias-Guiu, Xavier, Olivera, Irene, Ochoa, Maria C., Labiano, Sara, Garasa, Saray, Rodriguez, Inmaculada, Vidal, August, Mancheño, Uxua, Hervás-Stubbs, Sandra, Azpilikueta, Arantza, Otano, Itziar, Aznar, M. Angela, Sanmamed, Miguel F., Inogés, Susana, Berraondo, Pedro, Teijeira, Álvaro, Melero, Ignacio
Published in Cancer cell (09.12.2019)
Published in Cancer cell (09.12.2019)
Get full text
Journal Article
Nivolumab Plus Ipilimumab for Treatment-Naïve Metastatic Uveal Melanoma: An Open-Label, Multicenter, Phase II Trial by the Spanish Multidisciplinary Melanoma Group (GEM-1402)
Piulats, José María, Espinosa, Enrique, de la Cruz Merino, Luis, Varela, Mar, Alonso Carrión, Lorenzo, Martín-Algarra, Salvador, López Castro, Rafael, Curiel, Teresa, Rodríguez-Abreu, Delvys, Redrado, Miriam, Gomà, Montserrat, Rullán, Antonio José, Calvo González, Alfonso, Berrocal-Jaime, Alfonso
Published in Journal of clinical oncology (20.02.2021)
Published in Journal of clinical oncology (20.02.2021)
Get full text
Journal Article
Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer
Piperno-Neumann, Sophie, Piulats, Jose Maria, Goebeler, Matthias, Galloway, Iain, Lugowska, Iwona, Becker, Jürgen C, Vihinen, Pia, Van Calster, Joachim, Hadjistilianou, Theodora, Proença, Rui, Caminal, Jose Maria, Rogasik, Muriel, Blay, Jean-Yves, Kapiteijn, Ellen
Published in Cancers (13.06.2019)
Published in Cancers (13.06.2019)
Get full text
Journal Article
Phase II study of pembrolizumab in docetaxel-pretreated patients with metastatic castration-resistant prostate cancer (mCRPC): Updated follow-up of cohorts (C) one to three from KEYNOTE-199
Goh, Jeffrey C., Piulats Rodriguez, Jose Maria M., Gross-Goupil, Marine, Vaishampayan, Ulka N., De Wit, Ronald, Alanko, Tuomo, Fukasawa, Satoshi, Tabata, Kenichi, Feyerabend, Susan, Berger, Raanan, Wu, Haiyan, Kim, Jeri, Schloss, Charles, De Bono, Johann S., Antonarakis, Emmanuel S.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Cabazitaxel versus enzalutamide/abiraterone in CARD eligible mCRPC patients with or without germline HRR defects
Romero-Laorden, Nuria, Lozano, Rebeca, Llacer Perez, Casilda, Piulats Rodriguez, Jose Maria M., Puente, Javier, Lorente, David, Medina, Ana, Cattrini, Carlo, Vitrone, Francesca, Almagro, Elena, Borrega, Pablo, Lainez, Nuria, Rivera, Leticia, Villatoro, Rosa, Hernandez, Amaia, Rodriguez-Vida, Alejo, López-Casas, Pedro P., Gallardo Diaz, Enrique, Castro, Elena, Olmos, David
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Pembrolizumab (pembro) plus enzalutamide (enza) in patients (pts) with abiraterone acetate (abi)-pretreated metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort C efficacy, safety, and biomarker results
Conter, Henry Jacob, Shore, Neal D., Berry, William R., Fong, Peter C.C., Piulats Rodriguez, Jose Maria M., Appleman, Leonard Joseph, Todenhöfer, Tilman, Gravis, Gwenaelle, Laguerre, Brigitte, Gurney, Howard, Retz, Margitta, Romano, Emanuela, Mourey, Loic, De Bono, Johann S., Kam, Audrey E., Emmenegger, Urban, Wu, Haiyan, Qiu, Ping, Schloss, Charles, Yu, Evan Y.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Biomarker analysis from the KEYNOTE-199 trial of pembrolizumab in patients (pts) with docetaxel-refractory metastatic castration-resistant prostate cancer (mCRPC)
Antonarakis, Emmanuel S., Piulats Rodriguez, Jose Maria M., Gross-Goupil, Marine, Goh, Jeffrey C., Vaishampayan, Ulka N., De Wit, Ronald, Alanko, Tuomo, Fukasawa, Satoshi, Tabata, Kenichi, Feyerabend, Susan, Berger, Raanan, Wu, Haiyan, Kim, Jeri, Schloss, Charles, Qiu, Ping, Suttner, Leah, Cristescu, Razvan, Marton, Matthew John, De Bono, Johann S.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Pembrolizumab (pembro) plus olaparib in patients (pts) with docetaxel-pretreated metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort A efficacy, safety, and biomarker results
Yu, Evan Y., Piulats Rodriguez, Jose Maria M., Gravis, Gwenaelle, Laguerre, Brigitte, Arranz Arija, Jose Angel, Oudard, Stephane, Fong, Peter C.C., Kolinsky, Michael Paul, Augustin, Marinela, Todenhöfer, Tilman, Kam, Audrey E., Gurney, Howard, Tafreshi, Ali, Retz, Margitta, Berry, William R., Mar, Nataliya, Wu, Haiyan, Qiu, Ping, Schloss, Charles, De Bono, Johann S.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Pembrolizumab (pembro) plus docetaxel and prednisone in patients (pts) with abiraterone acetate (abi) or enzalutamide (enza)-pretreated metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort B efficacy, safety and, biomarker results
Sridhar, Srikala S., Kolinsky, Michael Paul, Gravis, Gwenaelle, Mourey, Loic, Piulats Rodriguez, Jose Maria M., Romano, Emanuela, Berry, William R., Gurney, Howard, Retz, Margitta, Appleman, Leonard Joseph, Boegemann, Martin, De Bono, Johann S., Joshua, Anthony M., Emmenegger, Urban, Conter, Henry Jacob, Laguerre, Brigitte, Wu, Haiyan, Qiu, Ping, Schloss, Charles, Yu, Evan Y.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
KEYNOTE-199: Pembrolizumab (pembro) for docetaxel-refractory metastatic castration-resistant prostate cancer (mCRPC)
De Bono, Johann S., Goh, Jeffrey CH, Ojamaa, Kristiina, Piulats Rodriguez, Jose Maria, Drake, Charles G., Hoimes, Christopher J., Wu, Haiyan, Poehlein, Christian Heinrich, Antonarakis, Emmanuel S.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Impact of treatment sequence on the outcomes of metastatic castration resistant prostate cancer patients (mCRPC) with germline BRCA2 mutations: A subanalysis of the PROREPAIR-B study
Romero-Laorden, Nuria, Castro, Elena, Medina, Ana, Lorente, David, González-Billalabeitia, Enrique, Méndez-Vidal, María José, Gonzalez del Alba, Aranzazu, Lozano, Rebeca, Borrega, Pablo, Fernandez Parra, Eva, Sáez, M Isabel, Garcia Carbonero, Iciar, Rodriguez Vida, Alejo, Morales Barrera, Rafael, del Pozo, Angela, Pritchard, Colin, Lapunzina, Pablo, Piulats Rodriguez, Jose Maria, Puente, Javier, Olmos, David
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Ergolide mediates anti-cancer effects on metastatic uveal melanoma cells and modulates their cellular and extracellular vesicle proteomes
Sundaramurthi, Husvinee, Tonelotto, Valentina, Wynne, Kieran, O'Connell, Fiona, O’Reilly, Eve, Costa-Garcia, Marcel, Kovácsházi, Csenger, Kittel, Agnes, Marcone, Simone, Blanco, Alfonso, Pallinger, Eva, Hambalkó, Szabolcs, Piulats Rodriguez, Jose Maria, Ferdinandy, Péter, O'Sullivan, Jacintha, Matallanas, David, Jensen, Lasse D., Giricz, Zoltán, Kennedy, Breandán N.
Published in Open research Europe (2023)
Published in Open research Europe (2023)
Get full text
Journal Article
Phase II study evaluating ipilimumab as a single agent in the first-line treatment of adult patients (Pts) with metastatic uveal melanoma (MUM): The GEM-1 trial
Piulats Rodriguez, Jose Maria, Ochoa de Olza, Maria, Codes, Manuel, Lopez-Martin, Jose A., Berrocal, Alfonso, García, Margarita, Gurpide, Alfonso, Homet, Blanca, Martin-Algarra, Salvador
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Predicting response to abiraterone acetate (AA): mRNA biomarker analysis of study COU-AA-302
Ricci, Deborah Sokol, Li, Weimin, Griffin, Thomas W., Gormley, Michael, Henitz, Erin, Ryan, Charles J., De Bono, Johann Sebastian, Attard, Gerhardt, van den Eertwegh, Alfons JM, Schrijvers, Dirk L., Gullo, John J., Suttmann, Henrik, Carles, Joan, Piulats Rodriguez, Jose Maria, Jones, Robert J., Logothetis, Christopher, Rathkopf, Dana E., Scher, Howard I., Efstathiou, Eleni
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Interim analysis (IA) results of COU-AA-302, a randomized, phase III study of abiraterone acetate (AA) in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
Ryan, Charles J., Smith, Matthew Raymond, De Bono, Johann Sebastian, Molina, Arturo, Logothetis, Christopher, De Souza, Paul L., Fizazi, Karim, Mainwaring, Paul N., Piulats Rodriguez, Jose Maria, Ng, Siobhan, Carles, Joan, Mulders, Peter, Kheoh, Thian San, Griffin, Thomas W., Small, Eric Jay, Scher, Howard I., Rathkopf, Dana E.
Published in Journal of clinical oncology (20.06.2012)
Published in Journal of clinical oncology (20.06.2012)
Get full text
Journal Article
Interim analysis (IA) results of COU-AA-302, a randomized, phase III study of abiraterone acetate in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
Ryan, Charles J., Smith, Matthew Raymond, De Bono, Johann Sebastian, Molina, Arturo, Logothetis, Christopher, De Souza, Paul L., Fizazi, Karim, Mainwaring, Paul N., Piulats Rodriguez, Jose Maria, Ng, Siobhan, Carles, Joan, Mulders, Peter, Kheoh, Thian San, Griffin, Thomas W., Small, Eric Jay, Scher, Howard I., Rathkopf, Dana E.
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article